LYSTEDA (tranexamic acid) Tablets
Date of Approval: November 16, 2009
Company: Xanodyne Pharmaceuticals, Inc.
Treatment for: Menorrhagia

ISTODAX (romidepsin) for Injection
Date of Approval: November 5, 2009
Company: Gloucester Pharmaceuticals
Treatment for: Cutaneous T-cell Lymphoma

PENNSAID(diclofenac sodium) Topical Solution
Date of Approval: November 4, 2009
Company: Nuvo Research Inc.
Treatment for: Osteoarthritis

ARZERRA(ofatumumab) Injection
Date of Approval: October 26, 2009
Company: GlaxoSmithKline
Treatment for: Chronic Lymphocytic Leukemia

VOTRIENT(pazopanib) Tablets
Date of Approval: October 19, 2009
Company: GlaxoSmithKline
Treatment for: Renal Cell Carcinoma

TWYNSTA(telmisartan and amlodipine) Tablets
Date of Approval: October 16, 2009
Company: Boehringer Ingelheim Pharmaceuticals Inc.
Treatment for: Hypertension

CERVARIX(human papillomavirus bivalent (types 16 and 18) vaccine, recombinant) Injection
Date of Approval: October 16, 2009
Company: GlaxoSmithKline
Treatment for: Human Papillomavirus Prophylaxis

LATEST DRUGS APPROVED FROM OCT 16 TO NOV 16.COLLECTED FROM DRUGS.COM